Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations

J. Bradley Oldemeyer, Richard J. Lund, Matt Koch, A. John Meares, Robert Dunlay

Research output: Contribution to journalArticle

33 Scopus citations

Abstract

Statin-fibrate combinations are commonly used to treat hyperlipidemia. These drugs have been previously reported to cause rhabdomyolysis with acute renal failure. Whether different statin-fibrate combinations have different risks for rhabdomyolysis is not known. We report a patient who developed rhabdomyolysis with acute renal failure pomptly after switching from the combination of pravastatin and fenofibrate to simvastatin and gemfibrozil.

Original languageEnglish (US)
Pages (from-to)127-128
Number of pages2
JournalCardiology
Volume94
Issue number2
DOIs
StatePublished - Dec 1 2000

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine
  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Rhabdomyolysis and acute renal failure after changing statin-fibrate combinations'. Together they form a unique fingerprint.

  • Cite this